In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection
Abdullah Ely, Prashika Singh, Tiffany S. Smith, Patrick Arbuthnot
Topics & Concepts
cccDNATranscription activator-like effector nucleaseHepatitis B virusVirologyBiologyEffectorHepatitis BGenome editingRNAVirusGeneHBsAgImmunologyGeneticsCRISPRCRISPR and Genetic EngineeringRNA Interference and Gene DeliveryVirus-based gene therapy research